Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp reaffirms FY 2014 guidance


Thursday, 30 Jan 2014 07:32am EST 

Celgene Corp:Affirms fiscal 2014 guidance.Says fiscal 2014 total revenue expected to be about $7.5 billion, an increase of 15 percent year-over-year.Says fiscal 2014 adjusted diluted EPS expected to be in the range of $7.00 to $7.20.Says fiscal 2014 GAAP diluted EPS is expected to be in the range of $5.54 to $5.92.Fiscal 2014 revenue of $7.5 bln - Thomson Reuters I/B/E/S. 

Company Quote

94.74
-0.915 -0.96%
4:00pm EDT